ArticleACS nano2025
An Implantable, Ultralow Distortion Bioelectronic Interface Integrating Light-Emitting Diodes and Graphene Field-Effect Transistors.
Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artifact-free, colocalized opto-electrophysiology enabled by a flexible, multimodal interface integrating transparent MXene microelectrodes and microLEDs.Biosensors & bioelectronics · 2026Article
- Nanomaterial Engineered Biosensors and Stimulus-Responsive Platform for Emergency Monitoring and Intelligent Diagnosis.Biosensors · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Microscale inorganic light-emitting diodes (μ-ILEDs) and field-effect transistors (FETs) are two widely used electronic components for high-resolution neural modulations and multimodal recordings. Integrating these devices into minimally invasive bioelectronic interfaces provides opportunities for investigating neural signaling at the cellular and molecular levels. However, such integration poses challenges due to crosstalk-induced signal distortions. Here, we present an implantable Opto-FET bioelectronic interface that incorporates μ-ILEDs and graphene-FETs in a compact configuration with ultralow distortions. Our work systematically identifies and mitigates two major sources of distortion: electromagnetic interference and photon-induced doping in graphene channels. We demonstrate that a combination of electromagnetic shielding and a light-blocking barrier effectively suppresses the distortion, reducing the maximum signal distortion level from 10-15% to 0.3-0.9%. We finally validate the distortion suppression strategy in vivo through real-time electrophysiological recordings during the operation of the μ-ILED. Overall, this study establishes a foundation for the development of next-generation multimodal neural probes enabling simultaneous optical stimulation and neural recordings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.